Skip to main content
Premium Trial:

Request an Annual Quote

BGI Genomics Nabs CE Mark for Colorectal Cancer Screening Test

NEW YORK – BGI Genomics announced on Wednesday that its colorectal cancer screening test has received CE marking.

The DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes can detect abnormal methylation of the genes in stool DNA from human fecal samples. The genes are highly specific markers for colorectal cancer cells, the company said in a statement.

The noninvasive test is intended to help diagnose patients who are recommended by clinicians to receive a diagnostic colonoscopy.

Shenzhen, China-based BGI Genomics is the clinical genetic testing and research services arm of China's BGI Group.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.